Danilo Rocco

2.0k total citations
55 papers, 995 citations indexed

About

Danilo Rocco is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Danilo Rocco has authored 55 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 42 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Danilo Rocco's work include Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Danilo Rocco is often cited by papers focused on Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Danilo Rocco collaborates with scholars based in Italy, Spain and United States. Danilo Rocco's co-authors include Umberto Malapelle, Cesare Gridelli, Giancarlo Troncone, Luigi Della Gravara, Claudio Bellevicine, Pasquale Pisapia, Andrea Bianco, Fabio Perrotta, Caterina De Luca and Francesco Pepe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Danilo Rocco

54 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danilo Rocco Italy 17 562 537 386 311 96 55 995
Annick Haller Belgium 11 612 1.1× 518 1.0× 292 0.8× 476 1.5× 62 0.6× 22 1.1k
Antonino Iaccarino Italy 18 321 0.6× 394 0.7× 333 0.9× 376 1.2× 97 1.0× 58 1.0k
Kevin Washetine France 10 460 0.8× 611 1.1× 295 0.8× 102 0.3× 62 0.6× 17 812
Olivier Bordone France 14 278 0.5× 287 0.5× 365 0.9× 226 0.7× 84 0.9× 34 671
Katia Zahaf France 11 468 0.8× 688 1.3× 276 0.7× 110 0.4× 56 0.6× 21 840
Alejandro Avilés‐Salas Mexico 14 249 0.4× 369 0.7× 186 0.5× 295 0.9× 62 0.6× 62 768
Lisha Ying China 16 233 0.4× 371 0.7× 229 0.6× 322 1.0× 74 0.8× 46 788
Sabrina Rossi Italy 19 403 0.7× 611 1.1× 181 0.5× 155 0.5× 40 0.4× 55 899
Alberto Pavan Italy 14 432 0.8× 591 1.1× 186 0.5× 174 0.6× 54 0.6× 36 855
Giuseppina Della Vittoria Scarpati Italy 15 172 0.3× 407 0.8× 313 0.8× 438 1.4× 58 0.6× 44 973

Countries citing papers authored by Danilo Rocco

Since Specialization
Citations

This map shows the geographic impact of Danilo Rocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danilo Rocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danilo Rocco more than expected).

Fields of papers citing papers by Danilo Rocco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danilo Rocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danilo Rocco. The network helps show where Danilo Rocco may publish in the future.

Co-authorship network of co-authors of Danilo Rocco

This figure shows the co-authorship network connecting the top 25 collaborators of Danilo Rocco. A scholar is included among the top collaborators of Danilo Rocco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danilo Rocco. Danilo Rocco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rocco, Danilo, Luigi Della Gravara, Angela Ragone, et al.. (2023). Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy. Cancers. 15(19). 4684–4684. 8 indexed citations
2.
Rocco, Danilo, Luigi Sapio, Luigi Della Gravara, Silvio Naviglio, & Cesare Gridelli. (2023). Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes. International Journal of Molecular Sciences. 24(3). 2433–2433. 16 indexed citations
3.
Viscardi, Giuseppe, Fabiana Vitiello, Alberto Servetto, et al.. (2022). Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review. Cancers. 14(23). 5810–5810. 4 indexed citations
4.
5.
Malapelle, Umberto, Sara Pilotto, Maria Lucia Reale, et al.. (2021). Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients. Critical Reviews in Oncology/Hematology. 169. 103536–103536. 11 indexed citations
6.
Marino, Federica Zito, Gerardo Botti, Gabriella Aquino, et al.. (2020). Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC. International Journal of Molecular Sciences. 21(14). 4927–4927. 11 indexed citations
7.
Rocco, Danilo, Luigi Della Gravara, Umberto Malapelle, Giancarlo Troncone, & Cesare Gridelli. (2019). Second-line avelumab in platinum-treated non-small cell lung cancer patients: comment on the JAVELIN Lung 200 clinical trial. Translational Cancer Research. 8(2). 2 indexed citations
8.
Rocco, Danilo, Luigi Della Gravara, & Cesare Gridelli. (2019). The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives. Current Clinical Pharmacology. 15(1). 11–19. 15 indexed citations
9.
Annunziata, Maria Carmela, Maria Ferrillo, Eleonora Cinelli, et al.. (2019). Retrospective Analysis of Skin Toxicity in Patients under Anti-EGFR Tyrosine Kinase Inhibitors: Our Experience in Lung Cancer. Open Access Macedonian Journal of Medical Sciences. 7(6). 973–977. 12 indexed citations
10.
Reclusa, Pablo, Jean‐François Laes, Umberto Malapelle, et al.. (2018). EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy. Translational Cancer Research. 8(1). 7 indexed citations
11.
Pisapia, Pasquale, Danilo Rocco, Francesco Pepe, et al.. (2018). EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review. Translational Cancer Research. 1(1). 5 indexed citations
12.
Rocco, Danilo, et al.. (2018). Immunotherapy as a targeted therapy in non-small cell lung cancer. Translational Cancer Research. 1(1). 2 indexed citations
13.
Pisapia, Pasquale, Danilo Rocco, Francesco Pepe, et al.. (2018). EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review. Translational Cancer Research. 8(S1). S64–S69. 14 indexed citations
14.
Bianco, Andrea, Umberto Malapelle, Danilo Rocco, Fabio Perrotta, & Gennaro Mazzarella. (2018). Targeting immune checkpoints in non small cell lung cancer. Current Opinion in Pharmacology. 40. 46–50. 48 indexed citations
15.
Pisapia, Pasquale, Francesco Pepe, Maria Russo, et al.. (2017). Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. Journal of Thoracic Disease. 9(S13). S1383–S1390. 29 indexed citations
16.
Malapelle, Umberto, Danilo Rocco, Mónica Garzón, et al.. (2017). Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients. British Journal of Cancer. 116(6). 802–810. 95 indexed citations
17.
Malapelle, Umberto, Simona Vatrano, Stefania Russo, et al.. (2015). EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer. Journal of Clinical Pathology. 68(9). 739–741. 6 indexed citations
18.
Botta, Cirino, Vito Barbieri, Domenico Ciliberto, et al.. (2013). Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. Cancer Biology & Therapy. 14(6). 469–475. 75 indexed citations
19.
Pallante, Pierlorenzo, Umberto Malapelle, Maria Teresa Berlingieri, et al.. (2012). UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. European Journal of Cancer. 49(5). 1117–1126. 28 indexed citations
20.
Malapelle, Umberto, Nicla De Rosa, Danilo Rocco, et al.. (2011). EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study. Journal of Clinical Pathology. 65(1). 87–91. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annick Haller Breakdown of academic impact, for papers by Antonino Iaccarino Breakdown of academic impact, for papers by Kevin Washetine Breakdown of academic impact, for papers by Olivier Bordone Breakdown of academic impact, for papers by Katia Zahaf Breakdown of academic impact, for papers by Alejandro Avilés‐Salas Breakdown of academic impact, for papers by Lisha Ying Breakdown of academic impact, for papers by Sabrina Rossi Breakdown of academic impact, for papers by Alberto Pavan Breakdown of academic impact, for papers by Giuseppina Della Vittoria Scarpati
Rankless by CCL
2026